Hyperfine (HYPR) announced the enrollment of 100 patients in its NEURO PMR study just 16 weeks after the study initiation, announced on April 15. The company said, “This milestone reflects strong clinician enthusiasm for accessible, point-of-care brain imaging and supports Hyperfine’s market expansion into outpatient neurology offices.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HYPR: